- Patent Title: Anti-tumor fibrillar human serum albumin methods and compositions
-
Application No.: US13738856Application Date: 2013-01-10
-
Publication No.: US09226951B2Publication Date: 2016-01-05
- Inventor: Shu-Mei Liang , Chi-Ming Liang
- Applicant: Academia Sinica
- Applicant Address: TW Taipei
- Assignee: ACADEMIA SINICA
- Current Assignee: ACADEMIA SINICA
- Current Assignee Address: TW Taipei
- Agency: Bozicevic, Field & Francis LLP
- Agent Pamela Sherwood
- Main IPC: C07K14/765
- IPC: C07K14/765 ; A61K38/38 ; A61K38/16 ; A61K47/48
Abstract:
Fibrillar human serum albumin was shown to be effective in the treatment of various types of cancers. Methods and compositions are disclosed for using fibrillar human serum albumin as a medicament to treat subjects having cancer.
Public/Granted literature
- US20130123183A1 Anti-tumor Fibrillar Human Serum Albumin Methods and Compositions Public/Granted day:2013-05-16
Information query
